Editas Medicine, Inc. (EDIT)

Editas Medicine Revenue

Editas Medicine had revenue of $61.00K in the quarter ending September 30, 2024, a decrease of -98.86%. This brings the company's revenue in the last twelve months to $61.76M, up 150.95% year-over-year. In the year 2023, Editas Medicine had annual revenue of $78.12M with 296.32% growth.

• Revenue (ttm): $61.76M
• Revenue Growth: +150.95%
• P/S Ratio: 3.20
• Revenue / Employee: $233,053
• Employees: 265
• Market Cap: 194.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	78.12M	58.41M	296.32%
Dec 31, 2022	19.71M	-5.83M	-22.83%
Dec 31, 2021	25.54M	-65.19M	-71.85%
Dec 31, 2020	90.73M	70.20M	341.93%
Dec 31, 2019	20.53M	-11.41M	-35.71%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.